WeVote
Log In

Bill

Bill

HB 5398

AN ACT CONCERNING THE REVIEW OF HEALTH CARE ENTITY TRANSACTIONS, THE EXPANSION OF EQUITABLE RELIEF AND ENFORCEMENT TOOLS AVAILABLE UNDER THE CONNECTICUT ANTITRUST ACT AND THE INCLUSION OF ADDITIONAL INFORMATION IN HOSPITAL PRICEMASTER FILINGS.

2026 Regular Session Introduced by Martin Looney

Connecticut expands antitrust enforcement, requires hospital price transparency, and adds regulatory review of healthcare transactions to combat consolidation-driven price increases.

PUBLIC HEARING 0304
#attorneygeneral #civilactions #electronicgovernmentinformation #healthstrategy #officeof #healthcarefacilities #healthcareproviders #hospitals #mergerandconsolidation #notices #reports #violations
0
WeVote Research Nonpartisan
Bill Summary · HB 5398

Legislative bill overview

HB 5398 establishes new regulatory review mechanisms for healthcare entity transactions in Connecticut, expands the state's antitrust enforcement tools specifically for healthcare markets, and requires hospitals to provide additional detailed information in their price filings. The bill aims to increase transparency and state oversight of consolidations and pricing practices in the healthcare sector.

Why is this important

Healthcare consolidation has accelerated nationwide, often resulting in higher prices and reduced competition. Connecticut's bill directly addresses concerns that large healthcare mergers may harm consumers through reduced choice and increased costs. Enhanced price transparency and stronger enforcement tools give regulators and the public better information about healthcare pricing while potentially preventing anticompetitive deals.

Potential points of contention

  • Compliance burden: Healthcare entities may argue that expanded filing requirements and transaction reviews create administrative costs that could be passed to consumers or delay beneficial mergers
  • Definition ambiguity: The bill's scope regarding which transactions trigger review and what constitutes "anticompetitive" behavior may be unclear, creating uncertainty for healthcare providers and potential legal disputes
  • State vs. federal authority: Connecticut's antitrust expansion could conflict with or duplicate existing federal antitrust oversight by the FTC and DOJ, raising questions about jurisdictional overlap and coordination

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.